https://www.selleckchem.com/pr....oducts/LY2228820.htm
After patient's exclusion due to lost of FU, FU less then 3 months, and/or a pending second stage procedure, 40 patients were eligible for final analysis. At median FU of 10 months (interquartile-range 5.0-18., RFS was 83%. After successful voiding trial, the postoperative median Qmax significantly improved (24.0 vs. 7.0 mL/s; p less then 0.01). Conversely, median residual urine decreased significantly (78 vs. 10 mL; p less then 0.01). Overall, 95% of patients stated that QoL improved and 90% were satisfied by the surgical outcome.
Like
Comment
Share
